Celastrus orbiculatus Extract Reduces Stemness of Gastric Cancer Stem Cells by Targeting PDCD4 and EIF3H

1. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Google Scholar | Crossref | Medline2. Smyth, EC, Nilsson, M, Grabsch, HI, van Grieken, NC, Lordick, F. Gastric cancer. Lancet. 2020;396:635-648.
Google Scholar | Crossref | Medline3. Thrift, AP, El-Serag, HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534-542.
Google Scholar | Crossref | Medline4. Al-Hajj, M, Wicha, MS, Benito-Hernandez, A, Morrison, SJ, Clarke, MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-3988.
Google Scholar | Crossref | Medline | ISI5. Lapidot, T, Sirard, C, Vormoor, J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645-648.
Google Scholar | Crossref | Medline | ISI6. Singh, SK, Clarke, ID, Hide, T, Dirks, PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267-7273.
Google Scholar | Crossref | Medline | ISI7. Cheng, L, Alexander, R, Zhang, S, et al. The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther. 2011;11:1131-1143.
Google Scholar | Crossref | Medline8. Al-Hajj, M, Becker, MW, Wicha, M, Weissman, I, Clarke, MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14:43-47.
Google Scholar | Crossref | Medline | ISI9. Valent, P, Bonnet, D, De Maria, R, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12:767-775.
Google Scholar | Crossref | Medline | ISI10. Cazet, AS, Hui, MN, Elsworth, BL, et al. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nat Commun. 2018;9:2897.
Google Scholar | Crossref | Medline11. De Jesus-Acosta, A, Sugar, EA, O’Dwyer, PJ, et al. Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Br J Cancer. 2020;122:498-505.
Google Scholar | Crossref | Medline12. Cortes, JE, Heidel, FH, Hellmann, A, et al. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. Leukemia. 2019;33:379-389.
Google Scholar | Crossref | Medline13. Morgensztern, D, Besse, B, Greillier, L, et al. Efficacy and safety of Rovalpituzumab Tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: results from the phase II TRINITY study. Clin Cancer Res. 2019;25:6958-6966.
Google Scholar | Crossref | Medline14. Goyal, L, Sirard, C, Schrag, M, et al. Phase I and biomarker study of the Wnt pathway modulator DKN-01 in combination with Gemcitabine/Cisplatin in Advanced Biliary tract cancer. Clin Cancer Res. 2020;26:6158-6167.
Google Scholar | Crossref | Medline15. Matsuhashi, S, Manirujjaman, M, Hamajima, H, Ozaki, I. Control mechanisms of the tumor suppressor PDCD4: expression and functions. Int J Mol Sci. 2019;20:2304.
Google Scholar | Crossref16. Zhao, J, Xiao, A, Liu, C, et al. The HIF-1A/miR-17-5p/PDCD4 axis contributes to the tumor growth and metastasis of gastric cancer. Signal Transduct Target Ther. 2020;5:46.
Google Scholar | Crossref | Medline17. Hwang, SK, Jeong, YJ, Chang, YC. PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression. Am J Cancer Res. 2020;10:424-439.
Google Scholar | Medline18. Hu, L, Liang, Y, Wu, K, et al. Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells. Ann Transl Med. 2021;9:114.
Google Scholar | Crossref | Medline19. Zhang, Y, Xiao, Y, Ma, Y, et al. ROS-mediated miR-21-5p regulates the proliferation and apoptosis of Cr(VI)-exposed L02 hepatocytes via targeting PDCD4. Ecotoxicol Environ Saf. 2020;191:110160.
Google Scholar | Crossref | Medline20. Cmarik, JL, Min, H, Hegamyer, G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA. 1999;96:14037-14042.
Google Scholar | Crossref | Medline | ISI21. Wang, Q, Yang, HS. The role of Pdcd4 in tumour suppression and protein translation. Biol Cell. 2018;110:2018.
Google Scholar | Crossref22. Jin, X, Jeon, HY, Joo, KM, et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 2011;71:3066-3075.
Google Scholar | Crossref | Medline | ISI23. Yu, Y, Kanwar, SS, Patel, BB, et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 2012;33:68-76.
Google Scholar | Crossref | Medline | ISI24. Zhang, N, Duan, WD, Leng, JJ, et al. STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma. Oncol Rep. 2015;33:1493-1498.
Google Scholar | Crossref | Medline25. Hirata, K, Suzuki, H, Imaeda, H, et al. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer. 2013;109:379-386.
Google Scholar | Crossref | Medline26. Polyak, K, Weinberg, RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-273.
Google Scholar | Crossref | Medline | ISI27. Medema, JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013;15:338-344.
Google Scholar | Crossref | Medline | ISI28. Zhu, Y, Liu, L, Hu, L, et al. Effect of Celastrus orbiculatus in inhibiting Helicobacter pylori induced inflammatory response by regulating epithelial mesenchymal transition and targeting miR-21/PDCD4 signaling pathway in gastric epithelial cells. BMC Complement Altern Med. 2019;19:91.
Google Scholar | Crossref | Medline29. Zheng, W, Li, Y, Su, Z, Zhang, J, Shi, F, Liang, W. EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle. Exp Cell Res. 2021;402:112488.
Google Scholar | Crossref | Medline30. Hu, Y, Wei, X, Lv, Y, et al. EIF3H interacts with PDCD4 enhancing lung adenocarcinoma cell metastasis. Am J Cancer Res. 2020;10:179-195.
Google Scholar | Medline31. Wang, X, Wang, H, Zhao, S, et al. Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation. Tissue Cell. 2018;53:23-29.
Google Scholar | Crossref | Medline32. des Georges, A, Dhote, V, Kuhn, L, et al. Structure of mammalian eIF3 in the context of the 43S preinitiation complex. Nature. 2015;525:491-495.
Google Scholar | Crossref | Medline33. Guo, X, Zhu, R, Luo, A, et al. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating snail stability. J Exp Clin Cancer Res. 2020;39:175.
Google Scholar | Crossref | Medline34. Shen, Y, Chen, BL, Zhang, QX, Zheng, YZ, Fu, Q. Traditional uses, secondary metabolites, and pharmacology of Celastrus species - a review. J Ethnopharmacol. 2019;241:111934.
Google Scholar | Crossref | Medline35. Chu, Z, Wang, H, Ni, T, et al. 28-Hydroxy-3-oxoolean-12-en-29-oic acid, a triterpene acid from Celastrus Orbiculatus extract, inhibits the migration and invasion of human gastric cancer cells in vitro. Molecules. 2019;24:2019.
Google Scholar | Crossref36. Wang, H, Gu, H, Feng, J, et al. Celastrus orbiculatus extract suppresses the epithelial-mesenchymal transition by mediating cytoskeleton rearrangement via inhibition of the Cofilin 1 signaling pathway in human gastric cancer. Oncol Lett. 2017;14:2926-2932.
Google Scholar | Crossref | Medline37. Wang, H, Tao, L, Ni, T, et al. Anticancer efficacy of the ethyl acetate extract from the traditional Chinese medicine herb Celastrus orbiculatus against human gastric cancer. J Ethnopharmacol. 2017;205:147-157.
Google Scholar | Crossref | Medline38. Zhu, Y, Liu, Y, Qian, Y, et al. Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway. Integr Cancer Ther. 2015;14:271-281.
Google Scholar | SAGE Journals | ISI39. Livak, KJ, Schmittgen, TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402-408.
Google Scholar | Crossref | Medline | ISI40. Long-Bao, W, Bo-Wen, Q, Yan-Xing, X. Establishment of human gastric cancer cell line (SGC-7901) intraperitoneally transplantable in nude mice. Recent Advances in Management of Digestive Cancers. Springer; 1993;416-418.
Google Scholar | Crossref41. Torre-Healy, LA, Berezovsky, A, Lathia, JD. Isolation, characterization, and expansion of cancer stem cells. Methods Mol Biol. 2017;1553:133-143.
Google Scholar | Crossref | Medline42. Li, R, Wu, X, Wei, H, Tian, S. Characterization of side population cells isolated from the gastric cancer cell line SGC-7901. Oncol Lett. 2013;5:877-883.
Google Scholar | Crossref | Medline | ISI43. Zhang, S, Balch, C, Chan, MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68:4311-4320.
Google Scholar | Crossref | Medline | ISI44. Rappa, G, Mercapide, J, Anzanello, F, et al. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res. 2008;314:2110-2122.
Google Scholar | Crossref | Medline | ISI45. Brungs, D, Aghmesheh, M, Vine, KL, Becker, TM, Carolan, MG, Ranson, M. Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol. 2016;51:313-326.
Google Scholar | Crossref | Medline46. Jeyamani, L, Jayarajan, J, Leelakrishnan, V, Swaminathan, M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J Pathol Microbiol. 2018;61:66-69.
Google Scholar | Crossref | Medline47. Yu, H, Zeng, J, Liang, X, et al. Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4). PLoS One. 2014;9:e105306.
Google Scholar | Crossref | Medline48. Sekar, D, Krishnan, R, Thirugnanasambantham, K, Rajasekaran, B, Islam, VI, Sekar, P. Significance of microRNA 21 in gastric cancer. Clin Res Hepatol Gastroenterol. 2016;40:538-545.
Google Scholar | Crossref |

留言 (0)

沒有登入
gif